All.Can – changing cancer care together

Regions covered:

Europe, Australia and Canada

Completed date:
Policy theme:
efficiency, waste, patient outcomes, innovation
Disease area:
Key partners and stakeholders:

Centre for Health Care, National Institute of Public Health, Slovenia
Clinique de Genolier
European CanCer Organisation (ECCO)
European Hospital and Healthcare Federation (HOPE)
European Cancer Patient Coalition (ECPC)
European Organisation for Research and Treatment of Cancer (EORTC)
GVG-Committee on Health Goals
International Brain Tumour Alliance
International Consortium for Health Outcomes Measurement (ICHOM)
Lieve Wierinck MEP
Marivek Health Consulting
Melanoma Patients Network Europe
Mélanome France
Oncopole-Sciences du Vivant et Santé Publique
Polish Cancer Patient Coalition
Save Your Skin Foundation Canada
University of Basel
Bristol-Myers Squibb
Johnson & Johnson

Signature output:
All.Can policy report (2018 update)

About this project

All.Can is an international initiative aiming to engage policymakers on the need to improve the efficiency of cancer care, focusing on better outcomes for patients.

The Health Policy Partnership provides secretariat for All.Can, a multidisciplinary, multi-sectoral initiative thataims to identify ways we can optimise the use of our resources in cancer care. All.Can is backed by leading representatives from patient organisations, policymakers, healthcare professionals, research and industry.

Visit the All.Can website for more information about All.Can, including members, publications, news and event.


All.Can activities for 2018 include:

  • a round table at the European Parliament, hosted with the MEPs Against Cancer (MAC) group, in collaboration with the European Cancer Patient Coalition (ECPC) and the European CanCer Organisation (ECCO)
  • a patient survey in 11 countries across the world, aiming to find out directly from patients how they experience inefficiency in cancer care. The survey is being operated in partnership with Quality Health
  • a quantitative and qualitative survey of the ECCO multidisciplinary membership, to gain insights from healthcare professionals on inefficiency in cancer care
  • the Improving Value in Cancer Care study, in partnership with the International Consortium for Health and Outcomes Measurement, which will measure value in breast and lung cancer care.

If you have questions about the All.Can initiative, please contact Suzanne Wait at

The All.Can initiative is made possible with financial support from Bristol-Myers Squibb (main sponsor), Amgen, MSD and Johnson & Johnson (sponsors). None of the content of All.Can discussions or activities is specific or biased to any specific treatment or therapy. All members contribute their time for free to the initiative, and all publications from the group reflect consensus of the members, who hold full editorial control.

Other projects